Product Information
ACYCLOVIR 5% CREAM is a generic product labeled by Viona Pharmaceuticals Inc., priced at $8.9916 per GM under NDC 72578010105. Its NADAC has been published 179 times since May 3, 2023.
FDA first approved this application on Feb 28, 2023. Its Orange Book therapeutic-equivalence code is BX.
The High Outlier badge above means this manufacturer's average price in the Acyclovir market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
50 mg/g
Manufacturer
Viona Pharmaceuticals Inc.NDC
72578010105
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
ACYCLOVIRApproval Type
Generic (ANDA)
FDA Application
ANDA206770FDA Approved
2/28/2023
TE Code
BX
On Market Since
3/3/2023
Pharmacological Classes
Price Statistics
The NADAC for ACYCLOVIR 5% CREAM has been published 179 times since May 3, 2023, and over the history we have for it it has declined 78.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.9916 per GM |
|---|---|
| All-time high | $41.9766 (Jul 12, 2023) |
| All-time low | $7.9189 (Nov 20, 2024) |
| 52-week high | $11.5170 |
| 52-week low | $8.9916 |
| Median price | $12.2143 |
| Average price | $16.9305 |
| Largest weekly change | +50.1% (Aug 21, 2024) |
| Weeks tracked | 179 |
| Tracking since | May 3, 2023 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Viona Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Acyclovir market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ACYCLOVIR 5% CREAM?
The current National Average Drug Acquisition Cost (NADAC) for ACYCLOVIR 5% CREAM, manufactured by Viona Pharmaceuticals Inc., is $8.9916 per GM (NDC 72578010105), effective Sep 30, 2026.
How has the price of ACYCLOVIR 5% CREAM changed over time?
Over the history we have for it, the NADAC for ACYCLOVIR 5% CREAM has declined 78.5%. It has been tracked across 179 weekly CMS publications since May 3, 2023.
What are the highest and lowest recorded NADAC prices for ACYCLOVIR 5% CREAM?
Since May 3, 2023, the NADAC for ACYCLOVIR 5% CREAM has ranged from a low of $7.9189 (Nov 20, 2024) to a high of $41.9766 (Jul 12, 2023), with a median of $12.2143 per GM.
Are there cheaper alternatives to ACYCLOVIR 5% CREAM?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ACYCLOVIR 5% CREAM in a comparable dosage form, but none are currently priced below it.
Who manufactures ACYCLOVIR 5% CREAM?
ACYCLOVIR 5% CREAM (NDC 72578010105) is labeled by Viona Pharmaceuticals Inc., and CMS classifies it as a generic product.